Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Genetic evidence for the adhesion protein IgSF9/Dasm1 to regulate inhibitory synapse development independent of its intracellular domain.

Mishra A, Traut MH, Becker L, Klopstock T, Stein V, Klein R.

J Neurosci. 2014 Mar 19;34(12):4187-99. doi: 10.1523/JNEUROSCI.3671-13.2014.

2.

[Alrternating hemiplegia of childhood: a case report and literature review].

Traut M, Cavagnari BM, Méndez JH, Amartino H.

Arch Argent Pediatr. 2012 Oct;110(5):e86-90. doi: 10.1590/S0325-00752012000500012. Review. Spanish.

3.

Are tissue samples from two different anatomical areas of the kidney necessary for adequate diagnosis?

Gerth J, Busch M, Illner N, Traut M, Gröne HJ, Wolf G.

Clin Nephrol. 2010 Oct;74(4):258-65.

PMID:
20875377
4.

Electrical activity suppresses axon growth through Ca(v)1.2 channels in adult primary sensory neurons.

Enes J, Langwieser N, Ruschel J, Carballosa-Gonzalez MM, Klug A, Traut MH, Ylera B, Tahirovic S, Hofmann F, Stein V, Moosmang S, Hentall ID, Bradke F.

Curr Biol. 2010 Jul 13;20(13):1154-64. doi: 10.1016/j.cub.2010.05.055. Epub 2010 Jun 24.

5.

Identification and characterization of Ca2+-activated K+ channels in granulosa cells of the human ovary.

Traut MH, Berg D, Berg U, Mayerhofer A, Kunz L.

Reprod Biol Endocrinol. 2009 Apr 8;7:28. doi: 10.1186/1477-7827-7-28.

6.

Serine phosphorylation of ephrinB2 regulates trafficking of synaptic AMPA receptors.

Essmann CL, Martinez E, Geiger JC, Zimmer M, Traut MH, Stein V, Klein R, Acker-Palmer A.

Nat Neurosci. 2008 Sep;11(9):1035-43. doi: 10.1038/nn.2171.

PMID:
19160501
9.

Effects of LU-111995 in three models of disrupted prepulse inhibition in rats.

Geyer MA, Swerdlow NR, Lehmann-Masten V, Teschendorf HJ, Traut M, Gross G.

J Pharmacol Exp Ther. 1999 Aug;290(2):716-24.

PMID:
10411583
10.

Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.

Löscher W, Lehmann H, Teschendorf HJ, Traut M, Gross G.

J Pharmacol Exp Ther. 1999 Mar;288(3):984-92.

PMID:
10027835
11.

MAO-A inhibition in brain after dosing with esuprone, moclobemide and placebo in healthy volunteers: in vivo studies with positron emission tomography.

Bergström M, Westerberg G, Németh G, Traut M, Gross G, Greger G, Müller-Peltzer H, Safer A, Eckernäs SA, Grahnér A, Långström B.

Eur J Clin Pharmacol. 1997;52(2):121-8.

PMID:
9174681
12.
13.

The fate of amezinium in humans and animals.

Traut M, Kummer H, Brode E.

Arzneimittelforschung. 1981;31(9a):1616-22.

PMID:
7197976
14.

Pharmacokinetics of amezinium in man.

Traut M, Brode E.

Arzneimittelforschung. 1981;31(9a):1605-15.

PMID:
7197975
15.

Pharmacokinetics of amezinium in rat and dog.

Traut M, Brode E, Neumann B, Kummer H.

Arzneimittelforschung. 1981;31(9a):1594-604.

PMID:
7197974
16.

Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action.

Traut M, Brode E, Hoffmann HD.

Arzneimittelforschung. 1981;31(9a):1566-74.

PMID:
7197971
17.

Determination of amezinium in body fluids.

Traut M, Morgenthaler H, Brode E.

Arzneimittelforschung. 1981;31(9a):1589-93.

PMID:
7030355
18.

[Pharmacokinetic study on N-(2-imidazolin-2-yl)-N-(4-indanyl)amine (indanazoline), a new rhinologic drug].

Neumann B, Brode E, Traut M.

Arzneimittelforschung. 1980;30(10):1771-85. German. No abstract available.

PMID:
6159901
19.

[Pharmacokinetics of tretinoin following cutaneous application].

Brode E, Kühne J, Kummer H, Traut M.

Arzneimittelforschung. 1974 Aug;24(8):1188-92. German. No abstract available.

PMID:
4479575
20.

[Pharmacokinetics of sulfaguanol in repeated oral administration in the human].

Denk R, Brode E, Kummer H, Traut M.

Arzneimittelforschung. 1973 Feb;23(2):187-91. German. No abstract available.

PMID:
4739827
22.

Cell susceptibility to the cytotoxic effect of the carcinogens dimethylnitrosamine and N-nitrosomethylurea.

Huberman E, Traut M, Sachs L.

J Natl Cancer Inst. 1970 Feb;44(2):395-402. No abstract available.

PMID:
11515081
23.

[New estratrienes with different nitrogen functional groups in 3-position].

Traut M, Hecker E.

Justus Liebigs Ann Chem. 1968;715:214-22. German. No abstract available.

PMID:
5685599
24.

[On the carcinogenic effect of 3-amino-delta 1.3.5.(10)-estratrienes and 2-nitroso-fluorenes].

Hecker E, Traut M, Hopp M.

Z Krebsforsch. 1968;71(1):81-8. German. No abstract available.

PMID:
4233401
25.

[On the chemistry of eodysone. V. Experiments on the preparation of steroidal-delta 7-6-ketones with 3,4-diol groups].

Rufer C, Hoffmeister H, Schairer H, Traut M.

Chem Ber. 1965 Jul;98(7):2383-93. German. No abstract available.

PMID:
5849854
26.

Environmental bone disease of hitherto undescribed type.

DODD NF, LEVY DW, JACKSON WP, TRAUT ML.

S Afr Med J. 1960 Jul 16;34:606-11. No abstract available.

PMID:
13723330

Supplemental Content

Support Center